Trial · NCT02867813
Adverse events1,940
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
41 to 60 of 1,940
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Splenic haemorrhage | Blood and lymphatic system disorders | Placebo in Parent Study | 0 | 2,532 | |
| serious | Splenic haemorrhage | Blood and lymphatic system disorders | Evolocumab in Parent Study | 1 | 2,499 | |
| serious | Acute cardiac event | Cardiac disorders | Placebo in Parent Study | 0 | 2,532 | |
| serious | Acute cardiac event | Cardiac disorders | Evolocumab in Parent Study | 1 | 2,499 | |
| serious | Acute coronary syndrome | Cardiac disorders | Placebo in Parent Study | 10 | 2,532 | |
| serious | Acute coronary syndrome | Cardiac disorders | Evolocumab in Parent Study | 6 | 2,499 | |
| serious | Acute left ventricular failure | Cardiac disorders | Placebo in Parent Study | 5 | 2,532 | |
| serious | Acute left ventricular failure | Cardiac disorders | Evolocumab in Parent Study | 3 | 2,499 | |
| serious | Acute myocardial infarction | Cardiac disorders | Placebo in Parent Study | 74 | 2,532 | |
| serious | Acute myocardial infarction | Cardiac disorders | Evolocumab in Parent Study | 52 | 2,499 | |
| serious | Angina pectoris | Cardiac disorders | Placebo in Parent Study | 56 | 2,532 | |
| serious | Angina pectoris | Cardiac disorders | Evolocumab in Parent Study | 52 | 2,499 | |
| serious | Angina unstable | Cardiac disorders | Placebo in Parent Study | 49 | 2,532 | |
| serious | Angina unstable | Cardiac disorders | Evolocumab in Parent Study | 37 | 2,499 | |
| serious | Aortic valve disease | Cardiac disorders | Placebo in Parent Study | 1 | 2,532 | |
| serious | Aortic valve disease | Cardiac disorders | Evolocumab in Parent Study | 1 | 2,499 | |
| serious | Aortic valve disease mixed | Cardiac disorders | Placebo in Parent Study | 1 | 2,532 | |
| serious | Aortic valve disease mixed | Cardiac disorders | Evolocumab in Parent Study | 0 | 2,499 | |
| serious | Aortic valve stenosis | Cardiac disorders | Placebo in Parent Study | 1 | 2,532 | |
| serious | Aortic valve stenosis | Cardiac disorders | Evolocumab in Parent Study | 1 | 2,499 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02867813/events?page=3